PATENT CLAIM ANALYSIS

Application Number: 15882689
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-06
Patent Classification: ["435", "235100"]

Abstract:
Provided are a highly-safe recombinant vaccinia virus that is effective in preventing the onset of symptoms due to infection by novel influenza viruses, and a vaccine for the novel influenza viruses containing the recombinant vaccinia virus. This recombinant vaccinia virus is capable of expressing the hemagglutinin protein genes of the novel influenza virus. This novel influenza vaccine contains the recombinant vaccinia virus.

Claim (Index 1):
An influenza vaccine comprising a recombinant vaccinia virus comprising an expression promoter and the entire or a part of cDNA coding for hemagglutinin protein derived from H5N1 avian influenza virus, wherein said vaccinia virus is an LC16m8 strain and said cDNA is the only non-vaccinia virus peptide- or protein-coding DNA in said recombinant vaccinia virus,\n wherein the cDNA coding for hemagglutinin protein is any one of DNA of: (i) DNA having the nucleotide sequence represented by SEQ ID NO:14; or (ii) DNA that hybridizes to DNA having a nucleotide sequence complementary to the nucleotide sequence represented by SEQ ID NO:14 under stringent conditions and that codes for hemagglutinin protein derived from a virus strain belonging to clade 2.3 of subtype H5; and wherein the expression promoter is a hybrid promoter having either DNA (a) or (b) below: (a) DNA having the nucleotide sequence represented by SEQ ID NO:6; or (b) DNA that hybridizes to DNA having a nucleotide sequence complementary to the nucleotide sequence represented by SEQ ID NO:6 under stringent conditions and that has a promoter activity.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 86.0
- Lexical Diversity: 1.83333
- Patent Class: 435.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15289106', '12748265', '15107074', '13982524', '13003570']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6327421816935462
- 35 USC 102 Novelty (BERT): 0.5603401689907633
- Combined Prediction Score: 0.625501980423268
- Mean Citation Score: 454.298122
- Max Citation Score: 472.80524
- Similarity Product: 355.455684282341

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test